EPRX

Eupraxia Pharmaceuticals
EPRX

Overview Fund Activity

9 hedge funds and large institutions have $5.63M invested in Eupraxia Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
$898K
2
Millennium Management
Millennium Management
New York
$31.3K
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
$178K

Top Sellers

1
UBS Group
UBS Group
Switzerland
$88.8K
2
SC
Scotia Capital
Ontario, Canada
$4.26M
3
1WA
180 Wealth Advisors
Washington
$33.3K
4
TWC
TD Waterhouse Canada
Ontario, Canada
$0
5
National Bank of Canada
National Bank of Canada
Quebec, Canada
$135
Name Holding Trade Value Shares
Change 		Shares
Change %
SC
1
Scotia Capital
Ontario, Canada
$4.26M -$14K -4,562 -0.3%
Royal Bank of Canada
2
Royal Bank of Canada
Ontario, Canada
$898K +$37.6K +11,858 +4%
Bank of Montreal
3
Bank of Montreal
Ontario, Canada
$178K +$23.5K +7,500 +15%
Goldman Sachs
4
Goldman Sachs
New York
$109K – – –
UBS Group
5
UBS Group
Switzerland
$88.8K -$15.9K -5,000 -15%
Raymond James Financial
6
Raymond James Financial
Florida
$36.8K +$36.8K +11,613 New
1WA
7
180 Wealth Advisors
Washington
$33.3K -$7.93K -2,500 -19%
Millennium Management
8
Millennium Management
New York
$31.3K +$31.3K +10,000 New
National Bank of Canada
9
National Bank of Canada
Quebec, Canada
$135 -$336 -107 -71%
TWC
10
TD Waterhouse Canada
Ontario, Canada
– -$3.84K -1,500 Closed